Taurel says Lilly will boost Cymbalta advertising

Share this article:
Lilly chief Sidney Taurel told Reuters the company would boost consumer advertising for Cymbalta as the firm seeks additional indications on the drug, including chronic pain, in the US and launches it in new markets abroad.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Pharmaceutical


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.